Life Sciences
Glasgow’s Microplate Dx secures £2.5m to fight antibiotic resistance
Published 10 months ago
Glasgow-based medical start-up Microplate Dx has successfully closed a £2.5 million seed funding round to accelerate the development of its point-of-care diagnostic platform.
Read on www.scottishfinancialnews.com →
Scottish Enterprise backs Össur with £400,000 for prosthetic innovations
Published 10 months ago
Livingston-based prosthetic technology specialist, Össur, has secured a £400,000 research and development grant from Scottish Enterprise, as part of a £2 million project aimed at advancing upper limb prosthetic technologies.
Read on www.scottishfinancialnews.com →
Scottish aquaculture mission to Norway aims for global growth
Published 11 months ago
A Scottish Government-backed delegation is travelling to Norway this week to showcase the strength of the country’s aquaculture supply chain and boost international trade opportunities for SMEs.
Read on www.scottishnews.com →
BDD secures £2m to accelerate drug trials and innovations
Published 11 months ago
Glasgow-based integrated drug formulation and clinical trials specialist BDD has secured a fresh £2 million investment to fuel its expansion, responding to a surge in demand for its proprietary drug delivery technology and its niche clinical trial services.
Read on www.scottishfinancialnews.com →
Edinburgh’s Cytomos gears up for 2024 launch with £4m funding
Published 11 months ago
Edinburgh-based life science firm, Cytomos, has successfully raised £4 million in a recent investment round for the development and market-testing of its Cytomos Dielectric Spectroscopy (CDS) technology.
Read on www.scottishfinancialnews.com →
Scottish tech firm Chemify raises £36m for digital chemistry revolution
Published 11 months ago
Chemify, a company specialising in digital chemical technologies, today announced the completion of a funding round worth £36 million.
Read on www.scottishfinancialnews.com →
Emblation reveals new £4m state-of-the-art Stirling headquarters
Published 11 months ago
Scottish health tech firm Emblation has unveiled its new £4 million state-of-the-art headquarters located in Stirling, marking a significant milestone in the firm’s global expansion journey.
Read on www.scottishfinancialnews.com →
Scottish health tech innovator launches $2m clinical trial
Published 1 year ago
Emblation, the Alloa-based health-tech innovator is undertaking a rigorous clinical trial which could transform the fortunes of its microwave treatments in the US.
Read on www.scottishfinancialnews.com →
Sir Tom Hunter’s West Coast Capital invests millions in Ellipses Pharma
Published 1 year ago
Sir Tom Hunter, through West Coast Capital (WCC), the investment arm of the Hunter family, has made a multi-million-pound contribution to Ellipses Pharma, an innovative cancer drug venture.
Read on www.scottishfinancialnews.com →
Scottish firm ACE Aquatec nets £2.5m investment to boost sustainable aquaculture
Published 1 year ago
Dundee-based aquaculture technology firm, ACE Aquatec, has received £2.5 million in investment from sustainability-focused investor, Earth Capital.
Read on www.scottishfinancialnews.com →
Pneumagen raises £8m to accelerate drug development
Published 1 year ago
St Andrews-based biotech firm Pneumagen has secured £8 million in financing from existing and new investors to support the continued Phase 2 development of Neumifil, a broad-spectrum antiviral, intranasal drug for the prophylaxis and treatment of viral respiratory tract infections (RTIs).
Read on www.scottishfinancialnews.com →
Merck to create 500 jobs with £30m investment into Glasgow and Stirling operations
Published 1 year ago
German science and technology giant, Merck, has announced plans to invest €35 million (£30m) in the expansion of its biosafety testing capabilities in Glasgow and Stirling.
Read on www.scottishfinancialnews.com →
Glasgow’s Novosound appoints former Intel exec amid North American expansion
Published 1 year ago
Glasgow-based ultrasound sensor firm Novosound has enlisted the expertise of former Intel executive David Jolliffe as its new CFO.
Read on www.scottishfinancialnews.com →
Edinburgh biotech secures £250,000 seed funding
Published 1 year ago
Edinburgh-based Lentitek Ltd, a developer of pioneering manufacturing technologies enabling economic delivery of advanced cell and gene therapies, announced today that it has secured £250,000 ($300,000 USD) in seed investment. This investment will be deployed to further advance its technology and commence initial commercial trials.
Read on www.scottishfinancialnews.com →
SAIC reaches 100-project milestone following latest £2.5m funding round
Published 1 year ago
The Sustainable Aquaculture Innovation Centre (SAIC) has announced support for a further six innovation projects valued at £2.5 million, taking its total investment in research and development initiatives to 100 projects.
Read on www.scottishfinancialnews.com →
Glasgow’s Microplate Dx secures £2.5m to fight antibiotic resistance
Published 10 months ago
Glasgow-based medical start-up Microplate Dx has successfully closed a £2.5 million seed funding round to accelerate the development of its point-of-care diagnostic platform.
Read on www.scottishfinancialnews.com →
Scottish Enterprise backs Össur with £400,000 for prosthetic innovations
Published 10 months ago
Livingston-based prosthetic technology specialist, Össur, has secured a £400,000 research and development grant from Scottish Enterprise, as part of a £2 million project aimed at advancing upper limb prosthetic technologies.
Read on www.scottishfinancialnews.com →
Scottish aquaculture mission to Norway aims for global growth
Published 11 months ago
A Scottish Government-backed delegation is travelling to Norway this week to showcase the strength of the country’s aquaculture supply chain and boost international trade opportunities for SMEs.
Read on www.scottishnews.com →
BDD secures £2m to accelerate drug trials and innovations
Published 11 months ago
Glasgow-based integrated drug formulation and clinical trials specialist BDD has secured a fresh £2 million investment to fuel its expansion, responding to a surge in demand for its proprietary drug delivery technology and its niche clinical trial services.
Read on www.scottishfinancialnews.com →
Edinburgh’s Cytomos gears up for 2024 launch with £4m funding
Published 11 months ago
Edinburgh-based life science firm, Cytomos, has successfully raised £4 million in a recent investment round for the development and market-testing of its Cytomos Dielectric Spectroscopy (CDS) technology.
Read on www.scottishfinancialnews.com →
Scottish tech firm Chemify raises £36m for digital chemistry revolution
Published 11 months ago
Chemify, a company specialising in digital chemical technologies, today announced the completion of a funding round worth £36 million.
Read on www.scottishfinancialnews.com →
Emblation reveals new £4m state-of-the-art Stirling headquarters
Published 11 months ago
Scottish health tech firm Emblation has unveiled its new £4 million state-of-the-art headquarters located in Stirling, marking a significant milestone in the firm’s global expansion journey.
Read on www.scottishfinancialnews.com →
Scottish health tech innovator launches $2m clinical trial
Published 1 year ago
Emblation, the Alloa-based health-tech innovator is undertaking a rigorous clinical trial which could transform the fortunes of its microwave treatments in the US.
Read on www.scottishfinancialnews.com →
Sir Tom Hunter’s West Coast Capital invests millions in Ellipses Pharma
Published 1 year ago
Sir Tom Hunter, through West Coast Capital (WCC), the investment arm of the Hunter family, has made a multi-million-pound contribution to Ellipses Pharma, an innovative cancer drug venture.
Read on www.scottishfinancialnews.com →
Scottish firm ACE Aquatec nets £2.5m investment to boost sustainable aquaculture
Published 1 year ago
Dundee-based aquaculture technology firm, ACE Aquatec, has received £2.5 million in investment from sustainability-focused investor, Earth Capital.
Read on www.scottishfinancialnews.com →
Pneumagen raises £8m to accelerate drug development
Published 1 year ago
St Andrews-based biotech firm Pneumagen has secured £8 million in financing from existing and new investors to support the continued Phase 2 development of Neumifil, a broad-spectrum antiviral, intranasal drug for the prophylaxis and treatment of viral respiratory tract infections (RTIs).
Read on www.scottishfinancialnews.com →
Merck to create 500 jobs with £30m investment into Glasgow and Stirling operations
Published 1 year ago
German science and technology giant, Merck, has announced plans to invest €35 million (£30m) in the expansion of its biosafety testing capabilities in Glasgow and Stirling.
Read on www.scottishfinancialnews.com →
Glasgow’s Novosound appoints former Intel exec amid North American expansion
Published 1 year ago
Glasgow-based ultrasound sensor firm Novosound has enlisted the expertise of former Intel executive David Jolliffe as its new CFO.
Read on www.scottishfinancialnews.com →
Edinburgh biotech secures £250,000 seed funding
Published 1 year ago
Edinburgh-based Lentitek Ltd, a developer of pioneering manufacturing technologies enabling economic delivery of advanced cell and gene therapies, announced today that it has secured £250,000 ($300,000 USD) in seed investment. This investment will be deployed to further advance its technology and commence initial commercial trials.
Read on www.scottishfinancialnews.com →
SAIC reaches 100-project milestone following latest £2.5m funding round
Published 1 year ago
The Sustainable Aquaculture Innovation Centre (SAIC) has announced support for a further six innovation projects valued at £2.5 million, taking its total investment in research and development initiatives to 100 projects.
Read on www.scottishfinancialnews.com →